Loading...
Loading...
Of the 5 tracked institutions holding ENGN, 4 have a 3-year clone track record — 4 of them beat the S&P. Average holder's clone alpha: +6.9pt. It's a gauge of who owns the name, not just how many.
Among the 5 tracked institutional investors we monitor, ENGN (ENGENE THERAPEUTICS INC) is held with a combined value of $4.53M across 2,545,305 shares. The largest holder is MILLENNIUM MANAGEMENT LLC with a position worth $1.67M. 5 funds opened new positions in the most recent quarter.
Total Institutional Value
$4.53M
Total Shares Held
2,545,305
Institutional Holders
5
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | MILLENNIUM MANAGEMENT LLC | $1.67M | 0.00% | New |
| 2 | RENAISSANCE TECHNOLOGIES LLC | $1.44M | 0.00% | New |
| 3 | CITADEL ADVISORS LLC | $1.24M | 0.00% | New |
| 4 | TWO SIGMA ADVISERS, LP | $156.22K | 0.00% | New |
| 5 | Point72 Asset Management, L.P. | $24.21K | 0.00% | New |
As of the latest SEC 13F filings, MILLENNIUM MANAGEMENT LLC is the largest institutional holder of ENGN with a position worth $1.67M, representing 0.00% of their portfolio. In total, 5 institutional investors hold ENGN with a combined value of $4.53M.
In the most recent quarter, 5 funds opened a new position in ENGN.
Institutional investors hold $4.53M worth of ENGN stock across 5 positions. The largest institutional holder is MILLENNIUM MANAGEMENT LLC with $1.67M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For ENGN, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their ENGN positions.
Alpha = the manager's 3-year clone return minus the S&P 500. A skilled roster is a stronger tell than a crowded one — though even skilled managers' edge doesn't reliably survive the 13F disclosure lag. Why →
None this quarter.
Last Close
$1.63
2026-10-21
YTD
-81.6%
2% of 52-week range
